AU2540499A - Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content - Google Patents

Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content

Info

Publication number
AU2540499A
AU2540499A AU25404/99A AU2540499A AU2540499A AU 2540499 A AU2540499 A AU 2540499A AU 25404/99 A AU25404/99 A AU 25404/99A AU 2540499 A AU2540499 A AU 2540499A AU 2540499 A AU2540499 A AU 2540499A
Authority
AU
Australia
Prior art keywords
active ingredient
pharmaceutical compositions
controlled release
potassium chloride
ingredient content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25404/99A
Other languages
English (en)
Inventor
Gabor Farago
Pal Fekete
Gabor Gunther
Blanka Lady
Tibor Nagy
Karoly Pataki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2540499A publication Critical patent/AU2540499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU25404/99A 1998-02-20 1999-02-19 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content Abandoned AU2540499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9800369 1998-02-20
HU9800369A HU221435B (en) 1998-02-20 1998-02-20 Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
PCT/HU1999/000013 WO1999042087A2 (en) 1998-02-20 1999-02-19 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content

Publications (1)

Publication Number Publication Date
AU2540499A true AU2540499A (en) 1999-09-06

Family

ID=89996172

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25404/99A Abandoned AU2540499A (en) 1998-02-20 1999-02-19 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content

Country Status (6)

Country Link
AU (1) AU2540499A (sk)
CZ (1) CZ299182B6 (sk)
HU (1) HU221435B (sk)
PL (1) PL193028B1 (sk)
SK (1) SK287281B6 (sk)
WO (1) WO1999042087A2 (sk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928312A1 (de) * 1999-06-16 2000-12-21 Schering Ag Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe
DE10347242A1 (de) 2003-10-10 2005-05-04 Wella Ag Farbstoffhaltige Pellets zum Färben von Keratinfasern
EP2023903B1 (en) * 2006-05-19 2014-04-23 EGIS Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság Process for the preparation and surface coating of pellets
DE102008063800A1 (de) 2008-12-19 2010-06-24 Henkel Ag & Co. Kgaa Beschichtete Färbemittel
CN102961363B (zh) * 2012-12-14 2014-09-17 河南中帅医药科技股份有限公司 氯化钾缓释胶囊
ES2725009T3 (es) 2016-03-04 2019-09-18 Laboratorio Reig Jofre S A Comprimidos con un alto contenido de principios activos útiles para el tratamiento de la pérdida de cabello o la estimulación de su crecimiento
EP4308286A1 (de) 2021-03-16 2024-01-24 Symrise AG Wirkstoffkapseln

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form

Also Published As

Publication number Publication date
SK287281B6 (sk) 2010-05-07
HUP9800369A1 (hu) 2000-08-28
HU221435B (en) 2002-10-28
WO1999042087A2 (en) 1999-08-26
WO1999042087A3 (en) 1999-11-25
PL343268A1 (en) 2001-08-13
CZ299182B6 (cs) 2008-05-14
CZ20002858A3 (cs) 2001-01-17
PL193028B1 (pl) 2007-01-31
HU9800369D0 (en) 1998-04-28
SK11882000A3 (sk) 2001-01-18

Similar Documents

Publication Publication Date Title
AU1689599A (en) Sustained release medicinal compositions
AU4338099A (en) Pharmaceutical composition containing a salt of acetaminophen and at least one other active ingredient
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
AU3977099A (en) Controlled release oral dosage form
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
AU4413299A (en) Stabilized pharmaceutical compositions
AU3192700A (en) Medicinal compositions
AU6740298A (en) Pharmaceutical composition
AU1574900A (en) Pharmaceutical compositions containing insulin
HU9802795D0 (en) Pharmaceutical compositions containing more active components
AU2005300A (en) Medicinal compositions
AU2003240654A1 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
AU8107998A (en) Pharmaceutical compositions
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU4779399A (en) Pharmaceutical levothyroxine preparation
HUP0102894A3 (en) A substituted triazolo-pyridazine derivative, pharmaceutical compositions containing them
AU5965399A (en) Pharmaceutically active composition
AU2002340573A1 (en) Powdery active ingredient formulations
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
PL327567A1 (en) Prolonged release granules containing dilthiazem as their active ingredient
AU2540499A (en) Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
AU9343098A (en) Pharmaceutical composition
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase